Hennef, Germany

Eric Hüfner

This inventor holds 2 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Chr. Hansen Hmo Gmbh, Jennewein Biotechnologie Gmbh. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Hüfner. Retrieved from https://idiyas.com/inventor/eric-hufner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Eric Hüfner: A Trailblazer in Fucosylated Compound Production

Introduction

Eric Hüfner, a prominent inventor based in Hennef, Germany, has made significant contributions to the field of biochemistry. With a notable portfolio of two patents, Hüfner is recognized for his innovative work in the synthesis of fucosylated compounds, showcasing his expertise in genetic modification techniques.

Latest Patents

Hüfner's latest patents reflect his pioneering research and understanding of fucosylation processes. His first patent, titled “Synthesis of fucosylated compounds,” outlines a method for creating genetically modified cells capable of producing fucosylated compounds. This method involves transforming cells to express key enzymes: fucose kinase, fucose-1-phosphate guanylyltransferase, and fucosyltransferase, enabling them to synthesize valuable fucosylated products.

The second patent, “Fucosyltransferases and their applications,” details the discovery of novel alpha-1,3-fucosyltransferases. This invention encompasses nucleic acid and amino acid sequences coding for these enzymes, and it offers innovative uses and methods for generating fucosylated products, including oligosaccharides, glycoproteins, and glycolipids, particularly focusing on 3-fucosyllactose.

Career Highlights

Throughout his career, Eric Hüfner has been associated with leading biotechnology firms, notably Chr. Hansen HMO GmbH and Jennewein Biotechnologie GmbH. His work at these organizations has significantly contributed to advancements in the biotechnological applications of fucosylated compounds.

Collaborations

Eric has collaborated with notable professionals in his field, including coworkers such as Julia Parkot and Stefan Jennewein. These collaborations have facilitated a productive exchange of ideas and innovations, further enhancing the scope of his research in fucosylation.

Conclusion

In summary, Eric Hüfner stands out as a dedicated inventor whose work on fucosylated compounds has the potential to impact various applications in biochemistry and biotechnology. His patents reveal a deep understanding of genetic modification and enzyme activity, positioning him as an influential figure in the innovation landscape. As he continues to work in this cutting-edge field, Eric Hüfner is poised to contribute even more groundbreaking advancements in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…